Table: Cosmos Pharmaceutical -Q1 group results

Cosmos Pharmaceutical

11/10/2022 07:00

Oct 11 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2022        Aug 31, 2021     May 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            206.12              189.41           813.50    
                 (+8.8 pct)                           (+7.7 pct)  
  Operating          8.90                8.56            30.00    
                 (+4.0 pct)                           (+0.7 pct)  
  Recurring          9.63                9.30            33.00    
                 (+3.5 pct)                           (+0.4 pct)  
  Net                6.48                6.24            23.20    
                 (+3.8 pct)                           (+0.2 pct)  
  EPS            163.68 yen          157.68 yen       585.87 yen  
  Ann Div                             80.00 yen        85.00 yen  
  -Q2 div                             40.00 yen        42.50 yen  
  -Q4 div                             40.00 yen        42.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T